SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) January 29, 2002
SALIX PHARMACEUTICALS, LTD.
--------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware
--------
(State or other jurisdiction of incorporation)
000-23265 94-3267443
- ------------------------------ -------------------------------
(Commission file Number) (IRS Employer ID Number)
8540 Colonnade Center Drive, Suite 501, Raleigh, North Carolina 27615
- --------------------------------------------------------------------------------
(Address of principal executive offices) Zip Code)
Registrant's telephone number, including area code (919) 862-1000
----------------------------
Item 5. Other Events
Emerald Asset Management, Inc. issued a press release on January 29,
2002 to announce that Salix Pharmaceuticals will be presenting at the Ninth
Annual Emerald Groundhog Day Investment Forum, scheduled for Tuesday, February
5, 2002 at the Wyndham Franklin Plaza Hotel in Philadelphia. Emerald will
provide an audio feed of the entire Forum via their Internet website at
www.teamerald.com. In addition, Salix's presentation will be broadcast live and
- -----------------
will be available for replay following the Forum. For broadcast and replay
information, contact the Emerald Internet website at www.teamerald.com.
-----------------
SIGNATURES
----------
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
SALIX PHARMACEUTICALS, LTD.
Date: January 29, 2002 By: /s/ Adam C. Derbyshire
----------------------
Adam C. Derbyshire
Vice President and Chief Financial
Officer